Healios KK (HLOSF)
0.965
-0.03
(-2.86%)
USD |
OTCM |
May 17, 09:30
Healios Cash from Investing (Quarterly): -2.480M for March 31, 2024
Cash from Investing (Quarterly) Chart
Historical Cash from Investing (Quarterly) Data
| Date | Value |
|---|---|
| March 31, 2024 | -2.480M |
| December 31, 2023 | -0.8731M |
| September 30, 2023 | -3.662M |
| June 30, 2023 | 0.2024M |
| March 31, 2023 | -3.657M |
| December 31, 2022 | -1.115M |
| September 30, 2022 | -0.1915M |
| June 30, 2022 | -3.289M |
| March 31, 2022 | -2.376M |
| December 31, 2021 | -1.720M |
| September 30, 2021 | -0.6757M |
| Date | Value |
|---|---|
| June 30, 2021 | -1.291M |
| March 31, 2021 | -3.021M |
| December 31, 2020 | -0.7734M |
| September 30, 2020 | -1.038M |
| June 30, 2020 | -8.699M |
| March 31, 2020 | -0.8815M |
| December 31, 2019 | 0.6573M |
| September 30, 2019 | -0.3687M |
| June 30, 2019 | -0.4642M |
| March 31, 2019 | -0.1181M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (Quarterly) Range, Past 5 Years
-8.699M
Minimum
Jun 2020
0.6573M
Maximum
Dec 2019
-1.786M
Average
-1.076M
Median
Cash from Investing (Quarterly) Benchmarks
| Takeda Pharmaceutical Co Ltd | -489.35M |
| Nxera Pharma Co Ltd | -0.3369M |
| PeptiDream Inc | 70.04M |
| AnGes Inc | -- |
| SanBio Co Ltd | -- |
Cash from Investing (Quarterly) Related Metrics
| Cash from Operations (Quarterly) | -4.144M |
| Cash from Financing (Quarterly) | 14.90M |
| Free Cash Flow | -19.34M |
| Free Cash Flow Per Share (Quarterly) | -0.0501 |
| Free Cash Flow to Equity (Quarterly) | -2.163M |
| Free Cash Flow to Firm (Quarterly) | 5.316M |
| Free Cash Flow Yield | -27.48% |